In this episode, Veera deals with one of the most classical concerns about life extension: that it might be a privilege only for rich people, creating a divide between an ever-young elite and poor people aging to death.
Liked the show? Let us know on Twitter at / lifespanio or our Discord server at / discord
Facebook: / lifespanio
LinkedIn: / lifespanio
Instagram: / lifespan.io
Website: https://www.leafscience.org/
Stock contents: Videoblocks
Charts from: Our World in Data, Gap Minder
Music:
Intro jingle courtesy of Kevin MacLeod - Incompetech.com
"Hungarian Rhapsody N.2" by Franz Liszt, licensed under cc-by-sa Germany license by Bernd Krueger, http://www.piano-midi.de
--------------------------
Sources and further reading
Data on cost and success rate of clinical trials
Mestre-Ferrandiz, J., Sussex, J., & Towse, A. (2012). The R&D cost of a new medicine. Monographs.
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33.
Fogel, D. B. (2018). Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemporary clinical trials communications, 11, 156-164.
Sertkaya, A., Wong, H.-H., Jessup, A., & Beleche, T. (2016). Key cost drivers of pharmaceutical clinical trials in the United States. Clinical Trials, 13(2), 117–126.
https://www.forbes.com/sites/matthewh...
https://www.clinicalleader.com/doc/th...
Data on poverty and inequality
https://www.gapminder.org/answers/how...
https://ourworldindata.org/global-eco...
https://ourworldindata.org/extreme-po...
Data on socialized healthcare
https://ourworldindata.org/grapher/he...
--------------------------
#Poverty #Aging #Inequality #LifeExtension #Rejuvenation
►Subscribe for more: http://www.youtube.com/user/LifespanI...
►This video is presented by LEAF. Please support our work by becoming a Lifespan Hero: http://lifespan.io/hero